Skip to content

Smoking Cessation Intervention in Public Housing

Social Ecological Based Smoking Cessation Intervention in Public Housing Neighborhoods

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01035151
Enrollment
420
Registered
2009-12-18
Start date
2009-07-31
Completion date
2018-05-15
Last updated
2018-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cigarette Smoking

Keywords

randomized cluster design, tobacco cessation, smoking cessation, African American

Brief summary

The major aim of this study is to test the effectiveness of a bundled, multi-level intervention (Sister to Sister) on smoking cessation outcomes in female smokers residing in public housing neighborhoods. Hypothesis 1.1: As compared to the control group, women receiving the Sister to Sister Intervention will have higher 7-day point prevalence quit rates at 6- and 12-months as validated by salivary cotinine. Hypothesis 1.2: As compared to the control group, women receiving the Sister to Sister Intervention will have higher 6- and 12-month prolonged smoking abstinence as validated by salivary cotinine.

Detailed description

This was a cluster randomized controlled study evaluating the effect of a multi-level intervention, Sister to Sister, on the smoking cessation in two Southeastern US metropolitan areas. Fourteen subsidized housing neighborhoods, eight in Charleston, SC and six in Augusta, GA, were pair matched based on size; with one neighborhood in each pair randomized to the intervention to ensure balanced recruitment between groups. Neighborhoods ranged in size from 22 to 33 participants with a total sample size of 409 women; neighborhoods were chosen as the primary sampling unit to prevent contamination of the outcome within neighborhoods, with women in the neighborhoods as secondary sampling unit. All statistical analyses were conducted using SAS 9.2 (SAS Institute, Cary, NC) with statistical significance at an alpha level of 0.05. Comparison between groups at baseline used t-tests for continuous variables and chi-square tests for categorical variables. The primary outcome of interest was smoking status which was dichotomized (smoker/non-smoker) at the 6 and 12 month measurements. Smoking status was determined by cotinine levels in saliva with non-smokers defined as those with cotinine levels of 14 ng/mL or less.

Interventions

BEHAVIORALExperimental

Neighborhood level interventions, peer group (counseling, NRT), and individual level (Coach/CHW)

BEHAVIORALControl

Written Cessation Materials

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Medical University of South Carolina
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 yrs of age and older, * female, resident of public housing, daily smoker

Exclusion criteria

* pregnant, * breastfeeding, * no intentions to quit smoking

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants Abstinent From Smoking12 monthReported abstinence validated by exhaled CO and saliva cotinine

Countries

United States

Participant flow

Recruitment details

Of the 34 subsidized housing neighborhoods in these two regions, the study was implemented in the 14 neighborhoods that met eligibility. Seven matched pairs were formed and randomly assigned one neighborhood in each pair to either the treatment condition or a delayed control condition. 27-32 participants enrolled in each neighborhood.

Pre-assignment details

Common reasons for exclusions were not a resident of the neighborhood, not an active smokers.

Participants by arm

ArmCount
Delayed Control
Women in the delayed control condition received culturally sensitive smoking cessation written materials at week 1, and mailed materials at week 6, 12, and 18. At the end of the study (i.e., after the 12 month data collection), participants were offered counseling, nicotine patches, and community health worker contacts. Control: Written Cessation Materials
209
Experimental
Women in neighborhoods randomized to the S2S received 24-week bundled multi-level intervention. Individual-led strategies were led by paid community health workers (CHWs). The CHWs provided 1:1 contact to reinforce social support, and enhanced self-efficacy with cessation attempts. A certified smoking cessation counselor led behavioral group sessions using the S2S handbook based on the PHS Guidelines. The weekly group sessions were initiated during the 1st week of the intervention, with a total of 6 group sessions over a 6-week period. Transdermal nicotine patches were offered to participants who set a quit date. Within the 24-week study period, the neighborhood tenant association, in partnership with study staff, implemented at least two neighborhood level anti-smoking activities Experimental: Neighborhood level interventions, peer group (counseling, NRT), and individual level (Coach/CHW)
200
Total409

Baseline characteristics

CharacteristicDelayed ControlExperimentalTotal
Age, Continuous43 years
STANDARD_DEVIATION 15.6
41 years
STANDARD_DEVIATION 14.1
42 years
STANDARD_DEVIATION 14
Ethnicity (NIH/OMB)
Hispanic or Latino
3 Participants4 Participants7 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
190 Participants180 Participants370 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
16 Participants16 Participants32 Participants
Nicotine Dependence Score4.8 units on a scale
STANDARD_DEVIATION 2.2
4.7 units on a scale
STANDARD_DEVIATION 2.2
4.7 units on a scale
STANDARD_DEVIATION 2.2
Race (NIH/OMB)
American Indian or Alaska Native
2 Participants1 Participants3 Participants
Race (NIH/OMB)
Asian
1 Participants0 Participants1 Participants
Race (NIH/OMB)
Black or African American
192 Participants157 Participants349 Participants
Race (NIH/OMB)
More than one race
2 Participants13 Participants15 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants1 Participants1 Participants
Race (NIH/OMB)
Unknown or Not Reported
1 Participants0 Participants1 Participants
Race (NIH/OMB)
White
11 Participants28 Participants39 Participants
Region of Enrollment
United States
209 Participants200 Participants409 Participants
Sex: Female, Male
Female
209 Participants200 Participants409 Participants
Sex: Female, Male
Male
0 Participants0 Participants0 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
0 / 2090 / 200
other
Total, other adverse events
0 / 2090 / 200
serious
Total, serious adverse events
0 / 2090 / 200

Outcome results

Primary

Number of Participants Abstinent From Smoking

Reported abstinence validated by exhaled CO and saliva cotinine

Time frame: 12 month

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Delayed ControlNumber of Participants Abstinent From Smoking10 Participants
ExperimentalNumber of Participants Abstinent From Smoking24 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026